CD244 and neoplasm: Additionally, the results of intraperitoneal tumor clearance experiments indicate that EAT2-deficient mice boast a stronger ability to clear myeloma cells compared to wild-type (WT) mice, suggesting that the binding of CD244 with EAT-2 plays an immunosuppressive role [17].